2-phenylbenzothiazole has been researched along with Disease Models, Animal in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bohlmann, L; Brazel, EB; Cunningham, BA; De Oliveira, DMP; Eijkelkamp, BA; El-Deeb, IM; Ganio, K; Iverson, AR; Keller, B; Maher, MJ; McDevitt, CA; McEwan, AG; Neville, SL; Rosch, JW; Sikanyika, M; Tan, A; Udagedara, SR; von Itzstein, M; Walker, MJ | 1 |
| Cao, M; Feng, X; Wang, W; Wang, Z; Xiang, H; Yang, X | 1 |
| Adlard, PA; Bush, AI; Doble, P; Finkelstein, DI; Hare, D; James, S; Lal, V; Parncutt, J | 1 |
| Adlard, PA; Bica, L; Bush, AI; Cappai, R; Crouch, PJ; Donnelly, PS; Filiz, G; Finkelstein, DI; Nurjono, M; White, AR | 1 |
| Barnham, KJ; Bush, AI; Cherny, RA; Kenche, VB; Link, CD; Masters, CL; McColl, G; Pukala, TL; Roberts, BR; Roberts, CM; Ryan, TM | 1 |
5 other study(ies) available for 2-phenylbenzothiazole and Disease Models, Animal
| Article | Year |
|---|---|
Dysregulation of Streptococcus pneumoniae zinc homeostasis breaks ampicillin resistance in a pneumonia infection model.
Topics: Ampicillin; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Clioquinol; Disease Models, Animal; Female; Homeostasis; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Streptococcus pneumoniae; Zinc | 2022 |
WBQ5187, a Multitarget Directed Agent, Ameliorates Cognitive Impairment in a Transgenic Mouse Model of Alzheimer's Disease and Modulates Cerebral β-Amyloid, Gliosis, cAMP Levels, and Neurodegeneration.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Anesthetics, General; Animals; Benzofurans; Biological Availability; Blood-Brain Barrier; Brain Chemistry; Clioquinol; Cyclic AMP; Disease Models, Animal; Drug Evaluation, Preclinical; Gliosis; Hippocampus; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Nausea; Neuroprotective Agents; Phosphodiesterase 4 Inhibitors; Resorcinols; Second Messenger Systems; Vomiting | 2019 |
Metal chaperones prevent zinc-mediated cognitive decline.
Topics: Analysis of Variance; Animals; Carrier Proteins; Cation Transport Proteins; Clioquinol; Cognition Disorders; Disease Models, Animal; Escape Reaction; Female; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Maze Learning; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Knockout; Patch-Clamp Techniques; Zinc | 2015 |
Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cells, Cultured; Clioquinol; Dendritic Spines; Disease Models, Animal; Female; Hippocampus; Ionophores; Memory; Metals; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurites; Neurogenesis; Synapses | 2011 |
Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Clioquinol; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents | 2012 |